Nikkei Biotech Features KumiChem™, DLeader’s AI Platform for RNA Drug Discovery

DLeader was featured in an interview with Nikkei Biotech, a leading Japanese biotechnology industry publication. The article explored the company’s vision and development of KumiChem™, an AI platform designed to support RNA drug discovery—from understanding targets and designing oligonucleotides to evaluating and prioritizing candidates.

DLeader is developing KumiChem™ to connect fragmented scientific data, specialized models, and research workflows through agentic AI. By integrating these capabilities, the company aims to make RNA drug discovery more efficient and systematic, while giving researchers greater visibility into the rationale behind design and evaluation decisions.

The interview also highlighted DLeader’s collaborations with researchers, scientific advisors, and partners across academia and biotechnology. The company will continue expanding partnerships with pharmaceutical companies, biotechnology companies, and research institutions in Japan and internationally to advance KumiChem™’s development and practical application.